Skip to search formSkip to main contentSkip to account menu

remifentanil 2 MG Injection [Ultiva]

Known as: Remifentanil Hydrochloride 1 mg in 1 mL INTRAVENOUS INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [Ultiva]_#2, Ultiva 2 MG Injection 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
Abstract Background Propofol and remifentanil often need to be co-administered via the same intravenous catheter line, which… 
2018
2018
Fear of treatment by an oral and maxillofacial (OMF) surgeon or the dentist is a widespread and deep-rooted phenomenon. A patient… 
2016
2016
Background Ultiva® is commonly administered intravenously for analgesia during general anaesthesia and its main constituent… 
2016
2016
BackgroundUltiva™ contains the potent short-acting μ-opioid receptor agonist remifentanil hydrochloride, and it is commonly… 
2006
2006
Remifentanil (Ultiva™), a 4-anilidopiperidine derivative of fentanyl, is an ultrashort-acting μ-opioid receptor agonist indicated… 
Review
2005
Review
2005
Remifentanil (Ultiva™), a fentanyl derivative, is an ultra-short acting, nonspecific esterase-metabolised, selective μ-opioid… 
2002
2002
Abstract Background : Remifentanil (Ultiva®) is a recently introduced esterase-metabolized potent opioid (EMO) μ-receptor agonist…